South Africa Cell Culture Market Size & Outlook, 2026-2033
The cell culture market in South Africa is expected to reach a projected revenue of US$ 178.1 million by 2033. A compound annual growth rate of 12.1% is expected of South Africa cell culture market from 2026 to 2033.
In terms of revenue, South Africa accounted for 0.4% of the global cell culture market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Middle East & Africa, Saudi Arabia cell culture market is projected to lead the regional market in terms of revenue in 2033.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 191.9 million by 2033.
In South Africa, organizations such as the Centre for Proteomic and Genomic Research (CPGR) enable cell culture-based screening for faster drug development, creating a demand for cell culture products. Key players operating in the country include Merck KGaA, Sartorius, Thermo Fisher Scientific, and others. Moreover, increased interest by global players in setting up manufacturing units for vaccines in the country is expected to contribute to market growth.
For instance, in September 2021, Numolux Group and Sinovac Biotech entered into a discussion to develop a new manufacturing facility for vaccines in South Africa for various diseases. This is anticipated to generate market demand for cell culture products in the coming years.
Furthermore, increasing workshops & symposiums on cell culture technologies in the country are anticipated to spread awareness about advanced cell biology technologies in South Africa. For instance, in 2019, the ninth IDA Symposium & Flow Cytometry Workshop was held in Cape Town, South Africa. Such workshops can increase the scientific awareness surrounding cell biology research and promote the adoption of cell culture products in the country.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Culture Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.24% in 2025.
Horizon Databook has segmented the South Africa cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2021 to 2033.
In South Africa, organizations such as the Centre for Proteomic and Genomic Research (CPGR) enable cell culture-based screening for faster drug development, creating a demand for cell culture products. Key players operating in the country include Merck KGaA, Sartorius, Thermo Fisher Scientific, and others. Moreover, increased interest by global players in setting up manufacturing units for vaccines in the country is expected to contribute to market growth.
For instance, in September 2021, Numolux Group and Sinovac Biotech entered into a discussion to develop a new manufacturing facility for vaccines in South Africa for various diseases. This is anticipated to generate market demand for cell culture products in the coming years.
Furthermore, increasing workshops & symposiums on cell culture technologies in the country are anticipated to spread awareness about advanced cell biology technologies in South Africa. For instance, in 2019, the ninth IDA Symposium & Flow Cytometry Workshop was held in Cape Town, South Africa. Such workshops can increase the scientific awareness surrounding cell biology research and promote the adoption of cell culture products in the country.
South Africa Cell Culture Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables
Instruments
South Africa Cell Culture Market Application Outlook (Revenue, USD Million , 2021-2033)
Biopharmaceutical Production
Drug Development
Diagnostics
Tissue Culture & Engineering
Cell and Gene Therapy
Toxicity Testing
Other Applications
Reasons to subscribe to Cell Culture Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cell Culture Market Outlook databook
Our clientele includes a mix of Cell Culture Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa Cell Culture Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Africa Cell Culture Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Africa Cell Culture Market, 2021-2033 (US$M)